Combined Vaccines
Showing 1 - 25 of >10,000
Safety, Immunogenicity, Vaccine, COVID-19 Vaccines Trial in Beijing (Vaccine)
Recruiting
- Safety
- +4 more
- Vaccine
-
Beijing, China
- +2 more
Mar 24, 2022
Healthy Participants Trial (Combination [RSVpreF+BNTb162b2], Bivalent BNT162b2 (original/Omi BA.4/BA.5), RSVpreF)
Not yet recruiting
- Healthy Participants
- Combination [RSVpreF+BNTb162b2]
- +4 more
- (no location specified)
May 31, 2023
Recurrent Glioblastoma Trial in Shanghai (Camrelizumab plus GSC-DCV, Camrelizumab plus Placebo)
Recruiting
- Recurrent Glioblastoma
- Camrelizumab plus GSC-DCV
- Camrelizumab plus Placebo
-
Shanghai, Shanghai, ChinaHuashan Hospital, Fudan University
Nov 28, 2021
SARS-CoV-2 Infection, Varicella, Measles Trial in Shanghai (Inactivated SARS-CoV-2 vaccine coadministered with vricella vaccine,
Not yet recruiting
- SARS-CoV-2 Infection
- +4 more
- Inactivated SARS-CoV-2 vaccine coadministered with vricella vaccine
- +2 more
-
Shanghai, Shanghai, ChinaShanghai Municipal Center for Disease Control and Prevention
Jul 17, 2023
Enterovirus 71 Inactivated Vaccine Combined Immunization in
Recruiting
- Hand, Foot and Mouth Disease
- EV71 Inactivated Vaccine
-
Baoshan, Shanghai, China
- +5 more
Jul 7, 2022
Papillomavirus Vaccines Trial in Rochester (Current care, Reminder-recall, Audit-and-feedback)
Recruiting
- Papillomavirus Vaccines
- Current care
- +3 more
-
Rochester, MinnesotaMayo Clinic
Jul 28, 2022
Human Papilloma Virus, HPV, HPV Positive Oropharyngeal Squamous Cell Carcinoma Trial in Chicago (HB-201, HB-202, Carboplatin)
Recruiting
- Human Papilloma Virus
- +3 more
- HB-201
- +4 more
-
Chicago, IllinoisUniversity of Chicago
Aug 11, 2022
Patients Who Have Received Gene Therapy Or Gene Marked Products
Recruiting
- Severe Combined Immunodeficiency
- +4 more
- Venipuncture
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Dec 10, 2021
Hand, Foot and Mouth Disease Trial in Ankang (Concomitant administration of EV71vaccine with EPI vaccines, Single injection of
Completed
- Hand, Foot and Mouth Disease
- Concomitant administration of EV71vaccine with EPI vaccines
- +2 more
-
Ankang, Shaanxi, ChinaHanbin District Center for Disease Control and Prevention
Jul 26, 2021
Meningococcal Infection (Healthy Volunteers) Trial in Worldwide (Meningococcal Polysaccharide (Serogroups A, C, Y, and W)
Completed
- Meningococcal Infection (Healthy Volunteers)
- Meningococcal Polysaccharide (Serogroups A, C, Y, and W) Tetanus Toxoid Conjugate Vaccine MenACYW conjugate vaccine
- +3 more
-
Budapest, Hungary
- +22 more
May 18, 2022
Influenza, Human, Pneumonia, Pneumococcal, Covid19 Trial in Chengdu, Shanghai, Taiyuan (COVAX+IIV4; COVAX+PPV23, COVAX only (1st
Completed
- Influenza, Human
- +2 more
- COVAX+IIV4; COVAX+PPV23
- +2 more
-
Chengdu, China
- +2 more
Oct 12, 2021
Influenza, Human, Pneumonia, Pneumococcal, COVID-19 Pneumonia Trial in Guangzhou, Zhengzhou, Wuhan (COVAX+PPV23;COVAX+IIV4,
Active, not recruiting
- Influenza, Human
- +2 more
- COVAX+PPV23;COVAX+IIV4
- +2 more
-
Guangzhou, Guangdong, China
- +2 more
Oct 5, 2021
Vaccines, Combined, Hexavalent Vaccine Trial in Germany, Italy, Spain (Vaxelis™)
Completed
- Vaccines, Combined
- Hexavalent Vaccine
- Vaxelis™
-
Bramsche, Niedersachsen, Germany
- +12 more
Sep 2, 2022
Pertussis Trial in Kampala (Standard of care vaccines, Boostagen, (BioNet-Asia))
Unknown status
- Pertussis
- Standard of care vaccines
- Boostagen, (BioNet-Asia)
-
Kampala, UgandaMUJHU Care Ltd
Nov 2, 2020
Polio, Polio Sero Conversion, Polio Sero Prevalence Trial in Karachi (Enhanced Community mobilization, Combined Oral Polio
Active, not recruiting
- Polio
- +3 more
- Enhanced Community mobilization
- Combined Oral Polio Vaccine and Inject able Polio Vaccine during SIA
-
Karachi, Sindh, PakistanAga Khan University
Feb 16, 2021
Infections, Meningococcal Trial in Worldwide (rMenB+OMV NZ vaccine, Meningococcal Groups A, C, W and Y Conjugate Vaccine
Active, not recruiting
- Infections, Meningococcal
- rMenB+OMV NZ vaccine
- +5 more
-
Chandler, Arizona
- +111 more
Jul 8, 2022
Fever After Vaccination, Fever, Seizures Fever Trial in United States (Pfizer-BioNTech COVID-19 Vaccine, Routine Childhood
Not yet recruiting
- Fever After Vaccination
- +2 more
- Pfizer-BioNTech COVID-19 Vaccine
- Routine Childhood Vaccinations
-
Oakland, California
- +4 more
Sep 8, 2023
Hepatitis B Trial in Quebec (Infanrix-hexa, Twinrix-Junior)
Recruiting
- Hepatitis B
- Infanrix-hexa, Twinrix-Junior
-
Quebec, Canada
- +1 more
Mar 2, 2020
Poliomyelitis Trial in Dhaka (Novel oral poliomyelitis vaccine type 1 (nOPV1), Novel oral poliomyelitis vaccine type 2 (nOPV2),
Not yet recruiting
- Poliomyelitis
- Novel oral poliomyelitis vaccine type 1 (nOPV1)
- +3 more
-
Dhaka, BangladeshInternational Centre for Diarrhoeal Disease Research
Nov 14, 2023
Vaccine Refusal, Vaccine-Preventable Diseases, Physician-Patient Relations Trial in Royal Oak (Immersive resident education,
Not yet recruiting
- Vaccine Refusal
- +2 more
- Immersive resident education
- Standardized patient (SP) encounter
-
Royal Oak, MichiganBeaumont Health System
Oct 5, 2023
Live Attenuated Mumps Vaccines in Junior High School Students
Completed
- Mumps
- Safety group
-
Baoji, Shanxi, China
- +2 more
Nov 25, 2021
Measles; Mumps; Rubella; Chickenpox Trial in United States (Investigational MMRV(H)NS vaccine, Investigational MM(H)RVNS
Recruiting
- Measles; Mumps; Rubella; Chickenpox
- Investigational MMRV(H)NS vaccine
- +3 more
-
Jonesboro, Arkansas
- +9 more
Jan 16, 2023
HIV Trial in United States (FP conjugate vaccine (25 mcg), FP conjugate vaccine (200 mcg), Trimer 6931 (100 mcg))
Not yet recruiting
- HIV
- FP conjugate vaccine (25 mcg)
- +5 more
-
Los Angeles, California
- +6 more
Jul 19, 2022
Healthy Volunteers (Meningococcal Infection) Trial in Puerto Rico, United States (Meningococcal polysaccharide (serogroups A,C,Y
Active, not recruiting
- Healthy Volunteers (Meningococcal Infection)
- Meningococcal polysaccharide (serogroups A,C,Y and W) tetanus toxoid conjugate vaccine (MenACYW conjugate vaccine)
- +7 more
-
Birmingham, Alabama
- +68 more
Jan 3, 2023
Malignant Tumor of Pancreas Metastatic to Peritoneal Surface, Malignant Peritoneal Mesothelioma, Peritoneal Carcinomatosis Trial
Completed
- Malignant Neoplasm of Pancreas Metastatic to Peritoneal Surface
- +2 more
- DC vaccine
- +3 more
-
Pittsburgh, PennsylvaniaUPMC Hillman Cancer Center
Jul 6, 2020